Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000093751-24-000882
Filing Date
2024-10-18
Accepted
2024-10-18 11:59:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 Travere_Therapeutics_Inc.htm SC 13G/A 53999
  Complete submission text file 0000093751-24-000882.txt   56157
Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114
Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

EIN.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks
(CF Office: 02 Finance)

Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Subject) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87088 | Film No.: 241379476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)